The Warsaw Stock Exchange-listed Polish medtech company, Medicalgorithmics, has signed an agreement with leading Korean distributor Wellysis – a spinoff of Samsung specializing in ECG monitoring, predictive analytics, and artificial intelligence models in healthcare. Under the agreement, the innovative DeepRhythm Platform (DRP) and DeepRhythmAI (DRAI) algorithms will be integrated with Wellysis’s flagship device, the FDA-approved S-Patch, and will be made available to all current and future customers of both companies, including those in the United States. This marks the eleventh agreement signed by Medicalgorithmics this year.
Since the beginning of the year, the Polish medtech has been rapidly expanding its partnerships and signing new agreements, driven by growing interest in its innovative products following the publication in the prestigious journal Nature Medicine, which confirmed the high effectiveness of the company’s advanced algorithms. The agreement signed with Samsung’s spinoff covers global cooperation, with a particular focus on the U.S. market, where Medicalgorithmics’ technology is gaining increasing recognition and traction.
“2025 has been a year of dynamic global expansion for us. The quality of our technology and products, along with our consistent execution of the development strategy, has led to a period of significant growth for Medicalgorithmics, particularly in the U.S. market. The results of the prestigious DRAI Martini study published in Nature Medicine triggered a surge of interest in our products, both in existing markets and in those new to us. Partnering with a technology company like Wellysis confirms the leading position of our technology and opens up further opportunities to scale the distribution of our unique solutions, especially in the U.S.,” said Jarosław Jerzakowski, Chief Operating and Sales Officer at Medicalgorithmics.
Wellysis, a Samsung spinoff, specializes in ECG monitoring, predictive analytics, and artificial intelligence models in healthcare. Its flagship product – the S-Patch – is an innovative, wireless wearable ECG monitoring device powered by Samsung’s Smart Health Processor. Through integration with Medicalgorithmics’ advanced DRP and DRAI software, the company will be able to analyze patient data even more effectively in real time, expand its offering, and grow its potential customer base.